Search

everythinglearnresearchcommunity

for

Search:↓

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Most transgender patients getting laser hair removal before gender-affirming surgery are already on hormone therapy, which might affect the hair removal process.

Feminizing hormone therapy increases kidney filtration rate.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Polycystic Ovarian Syndrome (PCOS) can be effectively treated with Ayurvedic dietary management.

Gender-affirming hormone therapy affects health risks and requires careful management, especially as transgender individuals age.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Both genetic and hormonal factors are crucial for bird sex differentiation, and disturbances can cause sex reversal.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

Male and female bodies respond differently to stress, influenced by hormones and development stages, with implications for stress-related diseases.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

The method accurately measures steroid hormones in hair to study hormone dynamics related to hair loss.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Gender affirming hormone therapy improves outcomes in gender affirmation surgery.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.